Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Other Non Operating Income (2021 - 2025)

Coeptis Therapeutics Holdings has reported Other Non Operating Income over the past 5 years, most recently at -$849176.0 for Q4 2025.

  • Quarterly results put Other Non Operating Income at -$849176.0 for Q4 2025, down 74.05% from a year ago — trailing twelve months through Dec 2025 was -$924229.0 (down 85.23% YoY), and the annual figure for FY2025 was $7004.0, up 102.05%.
  • Other Non Operating Income for Q4 2025 was -$849176.0 at Coeptis Therapeutics Holdings, down from $151993.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for COEPW hit a ceiling of $151993.0 in Q3 2025 and a floor of -$849176.0 in Q4 2025.
  • Median Other Non Operating Income over the past 5 years was $16.0 (2021), compared with a mean of -$139648.9.
  • Biggest five-year swings in Other Non Operating Income: tumbled 992.2% in 2023 and later surged 247400.0% in 2024.
  • Coeptis Therapeutics Holdings' Other Non Operating Income stood at -$57.0 in 2021, then skyrocketed by 146914.04% to $83684.0 in 2022, then tumbled by 992.2% to -$746625.0 in 2023, then skyrocketed by 34.65% to -$487906.0 in 2024, then crashed by 74.05% to -$849176.0 in 2025.
  • The last three reported values for Other Non Operating Income were -$849176.0 (Q4 2025), $151993.0 (Q3 2025), and -$338460.0 (Q2 2025) per Business Quant data.